Bone mineral content and collagen defects in osteogenesis imperfecta
- PMID: 10565454
- DOI: 10.1080/08035259950168135
Bone mineral content and collagen defects in osteogenesis imperfecta
Abstract
Whole-body and spine dual-energy X-ray absorptiometry was done in 63 patients with osteogenesis imperfecta aged 5 to 63 y, and the results were compared with OI types and collagen defects. Bone mineral content (BMC)-for-age, bone area (BA)-for-age, bone mineral density (BMD)-for-age, and BMC-for-BA were reduced, especially in patients with OI III/IV and/or in those with a qualitative collagen defect. BA-for-height was normal. Some patients with OI I and/or a quantitative collagen defect had BMD at or above -2 z-scores. We conclude (i) that both BMC and BMD differ significantly between OI types and collagen defects, (ii) that reduced BMC-for-age in OI patients is due mainly to reduced height ("short bones") and reduced BMC-for-BA ("light bones"), whereas BA-for-height ("bone width") is normal, (iii) that most OI patients have lower than average BMC, but in some mildly affected patients brittleness may exist with only small reductions in BMC.
Similar articles
-
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.Osteoporos Int. 2015 Oct;26(10):2431-40. doi: 10.1007/s00198-015-3156-4. Epub 2015 May 9. Osteoporos Int. 2015. PMID: 25956285
-
Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.J Pediatr. 1996 Sep;129(3):432-9. doi: 10.1016/s0022-3476(96)70077-x. J Pediatr. 1996. PMID: 8804334
-
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.Bone. 2016 Jun;87:11-8. doi: 10.1016/j.bone.2016.02.015. Epub 2016 Mar 5. Bone. 2016. PMID: 26957348
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Recent progress in diagnosis and treatment of osteogenesis imperfecta.Acta Paediatr Jpn. 1997 Aug;39(4):521-7. doi: 10.1111/j.1442-200x.1997.tb03631.x. Acta Paediatr Jpn. 1997. PMID: 9316304 Review.
Cited by
-
Bone mineral density in developing children with osteogenesis imperfecta: a longitudinal study with 9 years of follow-up.Acta Orthop. 2013 Aug;84(4):431-6. doi: 10.3109/17453674.2013.831321. Acta Orthop. 2013. PMID: 23992144 Free PMC article.
-
The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.Ital J Pediatr. 2014 Jun 7;40:55. doi: 10.1186/1824-7288-40-55. Ital J Pediatr. 2014. PMID: 24906390 Free PMC article. Review.
-
New perspectives on osteogenesis imperfecta.Nat Rev Endocrinol. 2011 Jun 14;7(9):540-57. doi: 10.1038/nrendo.2011.81. Nat Rev Endocrinol. 2011. PMID: 21670757 Free PMC article. Review.
-
Pediatric DXA: clinical applications.Pediatr Radiol. 2007 Jul;37(7):625-35. doi: 10.1007/s00247-007-0450-0. Epub 2007 Apr 13. Pediatr Radiol. 2007. PMID: 17431606 Free PMC article. Review.
-
Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.J Bone Miner Res. 2010 Feb;25(2):247-61. doi: 10.1359/jbmr.090720. J Bone Miner Res. 2010. PMID: 19594296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical